Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C, Campbell H, Kyaw MH, Nair H.

J Glob Health. 2019 Jun;9(1):010407. doi: 10.7189/jogh.09.010407.

2.

OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli.

Livermore DM, Day M, Cleary P, Hopkins KL, Toleman MA, Wareham DW, Wiuff C, Doumith M, Woodford N.

J Antimicrob Chemother. 2019 Feb 1;74(2):326-333. doi: 10.1093/jac/dky453.

PMID:
30388219
3.

Trends in mortality following Clostridium difficile infection in Scotland, 2010-2016: a retrospective cohort and case-control study.

Banks A, Moore EK, Bishop J, Coia JE, Brown D, Mather H, Wiuff C.

J Hosp Infect. 2018 Oct;100(2):133-141. doi: 10.1016/j.jhin.2018.07.023. Epub 2018 Jul 25.

PMID:
30055220
4.

The Need for European Surveillance of CDI.

Wiuff C, Banks AL, Fitzpatrick F, Cottom L.

Adv Exp Med Biol. 2018;1050:13-25. doi: 10.1007/978-3-319-72799-8_2. Review.

PMID:
29383661
5.

Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform.

Malcolm W, Fletcher E, Kavanagh K, Deshpande A, Wiuff C, Marwick C, Bennie M.

J Antimicrob Chemother. 2018 Jan 1;73(1):223-230. doi: 10.1093/jac/dkx363.

6.

First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit.

Inkster T, Coia J, Meunier D, Doumith M, Martin K, Pike R, Imrie L, Kane H, Hay M, Wiuff C, Wilson J, Deighan C, Hopkins KL, Woodford N, Hill R.

J Hosp Infect. 2017 Dec;97(4):397-402. doi: 10.1016/j.jhin.2017.07.003. Epub 2017 Jul 8.

PMID:
28698020
7.

Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations.

Balsells E, Filipescu T, Kyaw MH, Wiuff C, Campbell H, Nair H.

J Glob Health. 2016 Dec;6(2):020410. doi: 10.7189/jogh.06.020410. Review.

8.

Cumulative and temporal associations between antimicrobial prescribing and community-associated Clostridium difficile infection: population-based case-control study using administrative data.

Kavanagh K, Pan J, Marwick C, Davey P, Wiuff C, Bryson S, Robertson C, Bennie M.

J Antimicrob Chemother. 2017 Apr 1;72(4):1193-1201. doi: 10.1093/jac/dkw528.

9.

Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.

Trepanier P, Mallard K, Meunier D, Pike R, Brown D, Ashby JP, Donaldson H, Awad-El-Kariem FM, Balakrishnan I, Cubbon M, Chadwick PR, Doughton M, Doughton R, Hardiman F, Harvey G, Horner C, Lee J, Lewis J, Loughrey A, Manuel R, Parsons H, Perry JD, Vanstone G, White G, Shetty N, Coia J, Wiuff C, Hopkins KL, Woodford N.

J Antimicrob Chemother. 2017 Feb;72(2):596-603. doi: 10.1093/jac/dkw414. Epub 2016 Sep 29.

PMID:
27687074
10.

Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013.

van Dorp SM, Kinross P, Gastmeier P, Behnke M, Kola A, Delmée M, Pavelkovich A, Mentula S, Barbut F, Hajdu A, Ingebretsen A, Pituch H, Macovei IS, Jovanović M, Wiuff C, Schmid D, Olsen KE, Wilcox MH, Suetens C, Kuijper EJ; European Clostridium difficile Infection Surveillance Network (ECDIS-Net) on behalf of all participants.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30293.

11.

Survey of Clostridium difficile infection surveillance systems in Europe, 2011.

Kola A, Wiuff C, Akerlund T, van Benthem BH, Coignard B, Lyytikäinen O, Weitzel-Kage D, Suetens C, Wilcox MH, Kuijper EJ, Gastmeier P; members of ECDIS-Net.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30291.

12.

Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales.

Guy R, Geoghegan L, Heginbothom M, Howe R, Muller-Pebody B, Reilly JS, Wilson J, Wiuff C, Wyatt T, Johnson AP.

J Antimicrob Chemother. 2016 Jun;71(6):1564-9. doi: 10.1093/jac/dkw018. Epub 2016 Feb 17.

PMID:
26892779
13.

KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region.

Findlay J, Hopkins KL, Doumith M, Meunier D, Wiuff C, Hill R, Pike R, Loy R, Mustafa N, Livermore DM, Woodford N.

J Antimicrob Chemother. 2016 May;71(5):1199-206. doi: 10.1093/jac/dkv476. Epub 2016 Feb 3.

14.

Sentinel community Clostridium difficile infection (CDI) surveillance in Scotland, April 2013 to March 2014.

Banks A, Brown DJ, Mather H, Coia JE, Wiuff C.

Anaerobe. 2016 Feb;37:49-53. doi: 10.1016/j.anaerobe.2015.12.008. Epub 2015 Dec 18.

PMID:
26708405
15.

Effects of immobilization and aerobic training on proteins related to intramuscular substrate storage and metabolism in young and older men.

Vigelsø A, Gram M, Wiuff C, Hansen CN, Prats C, Dela F, Helge JW.

Eur J Appl Physiol. 2016 Mar;116(3):481-94. doi: 10.1007/s00421-015-3302-x. Epub 2015 Dec 1.

PMID:
26626913
16.

iCap: Instrumented assessment of physical capability.

Godfrey A, Lara J, Del Din S, Hickey A, Munro CA, Wiuff C, Chowdhury SA, Mathers JC, Rochester L.

Maturitas. 2015 Sep;82(1):116-22. doi: 10.1016/j.maturitas.2015.04.003. Epub 2015 Apr 14.

17.

Instrumented assessment of test battery for physical capability using an accelerometer: a feasibility study.

Godfrey A, Lara J, Munro CA, Wiuff C, Chowdhury SA, Del Din S, Hickey A, Mathers JC, Rochester L.

Physiol Meas. 2015 May;36(5):N71-83. doi: 10.1088/0967-3334/36/5/N71. Epub 2015 Apr 22.

PMID:
25903399
18.
19.

The Effect of Reduced Physical Activity and Retraining on Blood Lipids and Body Composition in Young and Older Adult Men.

Nørregaard J, Gram M, Vigelsø A, Wiuff C, Kuhlman AB, Helge JW, Dela F.

J Aging Phys Act. 2015 Oct;23(4):489-95. doi: 10.1123/japa.2014-0079. Epub 2014 Nov 21.

PMID:
25415262
20.

Control of Clostridium difficile infection in the hospital setting.

Wiuff C, Murdoch H, Coia JE.

Expert Rev Anti Infect Ther. 2014 Apr;12(4):457-69. doi: 10.1586/14787210.2014.894459. Epub 2014 Mar 3. Review.

PMID:
24579852
21.

Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.

Marwick CA, Yu N, Lockhart MC, McGuigan CC, Wiuff C, Davey PG, Donnan PT.

J Antimicrob Chemother. 2013 Dec;68(12):2927-33. doi: 10.1093/jac/dkt257. Epub 2013 Jul 3.

PMID:
23825381
22.

UK laboratory diagnosis of Clostridium difficile infection: in a state of transition, confusion, or both?

Jones BL, Wiuff C, Coia JE.

J Hosp Infect. 2012 Jul;81(3):216. doi: 10.1016/j.jhin.2012.04.012. Epub 2012 May 24. No abstract available.

PMID:
22633279
23.

The diagnosis of C. difficile infection (CDI) - two steps forwards?

Coia JE, Eastaway A, Wiuff C.

J Infect. 2011 Nov;63(5):398-9; author reply 400-1. doi: 10.1016/j.jinf.2011.07.007. Epub 2011 Jul 23. No abstract available.

PMID:
21802445
24.

Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme.

Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, Eastaway A, Seaton RA, Watson E, Gillies E, Davey P, Bennie M; Scottish Antimicrobial Prescribing Group.

Int J Antimicrob Agents. 2011 Jul;38(1):16-26. doi: 10.1016/j.ijantimicag.2011.02.005. Epub 2011 Apr 22. Review.

PMID:
21515030
25.

The epidemiology of Clostridium difficile in Scotland.

Wiuff C, Brown DJ, Mather H, Banks AL, Eastaway A, Coia JE.

J Infect. 2011 Apr;62(4):271-9. doi: 10.1016/j.jinf.2011.01.015. Epub 2011 Feb 22.

PMID:
21300104
26.

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL.

Euro Surveill. 2008 Jul 31;13(31). pii: 18942.

27.

Infection control measures to limit the spread of Clostridium difficile.

Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P; European C difficile-Infection Control Group; European Centre for Disease Prevention and Control (ECDC), van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O'Driscoll J, Patel B, Stone S, Wiuff C.

Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20. doi: 10.1111/j.1469-0691.2008.01992.x. Review.

28.

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.

Kuijper EJ, Coignard B, Brazier JS, Suetens C, Drudy D, Wiuff C, Pituch H, Reichert P, Schneider F, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Barbut F, Delmée M, Wilcox M, Pearson A, Patel BC, Brown DJ, Frei R, Akerlund T, Poxton IR, Tüll P.

Euro Surveill. 2007 Jun 1;12(6):E1-2.

PMID:
17991399
29.

Antibiotic treatment in vitro of phenotypically tolerant bacterial populations.

Wiuff C, Andersson DI.

J Antimicrob Chemother. 2007 Feb;59(2):254-63. Epub 2006 Nov 13.

PMID:
17105735
30.

Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.

Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, Levin BR.

Antimicrob Agents Chemother. 2005 Apr;49(4):1483-94.

31.

Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.

Regoes RR, Wiuff C, Zappala RM, Garner KN, Baquero F, Levin BR.

Antimicrob Agents Chemother. 2004 Oct;48(10):3670-6.

33.

Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Aarestrup FM, Wiuff C, Mølbak K, Threlfall EJ.

Antimicrob Agents Chemother. 2003 Feb;47(2):827-9. No abstract available.

34.

Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations.

Wiuff C, Lykkesfeldt J, Aarestrup FM, Svendsen O.

J Vet Pharmacol Ther. 2002 Oct;25(5):335-42.

PMID:
12423223
35.

Immunochemical analyses of serum antibodies from pig herds in a Salmonella non-endemic region.

Wiuff C, Thorberg BM, Engvall A, Lind P.

Vet Microbiol. 2002 Feb 26;85(1):69-82.

PMID:
11792494
36.

New technology for regiospecific covalent coupling of polysaccharide antigens in ELISA for serological detection.

Jauho ES, Boas U, Wiuff C, Wredstrøm K, Pedersen B, Andresen LO, Heegaard PM, Jakobsen MH.

J Immunol Methods. 2000 Aug 28;242(1-2):133-43.

PMID:
10986396
37.

Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark.

Wiuff C, Madsen M, Baggesen DL, Aarestrup FM.

Microb Drug Resist. 2000 Spring;6(1):11-7.

PMID:
10868803
38.
39.

Oedema disease caused by O-rough Escherichia coli.

Aarestrup FM, Jorsal SE, Ahrens P, Wiuff C, Scheutz F.

Vet Rec. 1996 Oct 12;139(15):373. No abstract available.

PMID:
8903022
40.

Cation-dependent interactions of calreticulin with denatured and native proteins.

Wiuff C, Houen G.

Acta Chem Scand. 1996 Sep;50(9):788-95.

PMID:
8817869

Supplemental Content

Support Center